| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24.5B | $24.3B | $24.1B | $24.9B | $21.8B | $5.1B | $5.2B | $5.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $9.8B | $9.7B | $9.1B | $9.9B | $9.3B | $2.0B | $2.1B | $2.2B |
| Net Income | $7.1B | $6.7B | $6.4B | $7.0B | $6.5B | $1.4B | $1.4B | $1.6B |
| EPS (Basic) | $12.00 | $11.10 | $10.47 | $11.24 | $9.98 | $2.05 | $2.03 | $2.13 |
| EPS (Diluted) | $11.98 | $11.09 | $10.45 | $11.21 | $9.95 | $2.05 | $2.02 | $2.12 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $69.7B | $67.7B | $67.1B | $65.4B | $63.5B | $62.4B | $61.7B | $59.1B |
| Current Assets | $4.6B | $4.0B | $4.1B | $4.0B | $3.6B | $4.2B | $3.5B | $4.2B |
| Cash & Equivalents | $1.3B | $1.0B | $1.1B | $1.0B | $1.0B | $1.8B | $0.8B | $1.3B |
| Total Liabilities | $51.2B | $50.8B | $52.3B | $53.3B | $49.4B | $45.4B | $43.5B | $38.7B |
| Current Liabilities | $5.0B | $5.3B | $5.1B | $5.5B | $5.7B | $4.2B | $4.4B | $4.6B |
| Stockholders' Equity | $18.5B | $16.9B | $14.8B | $12.2B | $14.2B | $17.0B | $18.1B | $20.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $9.3B | $9.3B | $8.4B | $9.4B | $9.0B | $8.5B | $8.6B | — |
| Investing Cash Flow | $-3.8B | $-3.3B | $-3.7B | $-3.5B | $-2.7B | $-2.7B | $-3.4B | — |
| Capital Expenditures | $3.8B | $3.5B | $3.6B | $3.6B | $2.9B | $2.9B | $3.5B | $3.4B |
| Financing Cash Flow | $-5.3B | $-6.1B | $-4.6B | $-5.9B | $-7.2B | $-4.9B | $-5.6B | — |